Everest Organics accepts resignation of Company Secretary Shweta Singh

Everest Organics Limited has accepted the resignation of Ms. Shweta Singh as Company Secretary and Compliance Officer, effective June 22, 2026. The resignation, citing personal reasons and career growth, was received by the company on June 21, 2026. The Managing Director will assume the role of Compliance Officer on an interim basis until a new appointment is made.

The company disclosed the change in a filing to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The resignation letter will be placed before the upcoming Board meeting for formal acceptance and noting, in accordance with the Companies Act, 2013 and SEBI LODR Regulations.

Resignation Details

The following table outlines the key particulars regarding the change in the compliance officer position:

Particulars	Details
Reason for change	Resignation
Name of outgoing Company Secretary	Ms. Shweta Singh, ACS No. 66353
Date of cessation	June 22, 2026
Reason for resignation	Personal reasons and Career growth.
Disclosure of relationships between directors	Not Applicable

Everest Organics stated that it will make necessary arrangements to appoint a new Company Secretary and Compliance Officer in accordance with applicable laws and will inform the stock exchanges subsequently. Until then, the Managing Director has been designated as the Compliance Officer.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-4.64%	-6.52%	-3.13%	-46.69%	-28.59%	-25.53%

Everest Organics Limited reported a net profit of ₹262.93 lakh for the quarter ended March 31, 2026, a significant increase from the ₹35.63 lakh recorded in the quarter ended December 31, 2025. Total revenue from operations for the quarter rose to ₹4,874.62 lakh, compared to ₹4,259.41 lakh in the previous quarter. For the full financial year, the company achieved a total revenue of ₹19,615.77 lakh and a net profit of ₹291.30 lakh for the period after tax and exceptional items.

The company's Board of Directors approved the audited financial results during a meeting held on May 29, 2026. The results were reviewed by the Audit Committee and are subject to an audit report by the statutory auditors. Everest Organics filed these results with the stock exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Summary

The financial statements indicate a strong performance in the final quarter of the fiscal year. The basic and diluted earnings per share (EPS) for the quarter ended March 31, 2026, stood at ₹2.69, up from ₹0.37 in the prior quarter. For the year ended March 31, 2026, the basic and diluted EPS were reported at ₹5.70.

Particulars	Quarter Ended 31-03-2026 (Audited)	Quarter Ended 31-12-2025 (Unaudited)	Year Ended 31-03-2026 (Audited)	Year Ended 31-03-2025 (Audited)
Total revenue from operations	4,874.62	4,259.41	19,615.77	4,093.48
Net Profit for the period after tax	262.93	35.63	291.30	554.65
Total comprehensive income	261.41	35.63	131.47	553.13
Basic EPS (in Rs.)	2.69	0.37	5.70	1.35

Operational Highlights

Equity share capital remained constant at ₹971.05 lakh throughout the reported periods. Other equity, excluding revaluation reserve, was reported at ₹6,576.77 lakh for the quarter ended March 31, 2026, compared to ₹6,315.37 lakh in the previous quarter. The company operates as an ISO 9001:2015 and WHO GMP certified entity.